Skip to content

HSCS

HeartSciences Inc.

NASDAQ · Healthcare · Medical - Devices · US

$3.73
+11.01%
Ask drillr

Income statement

MetricTTM2025202520242023
Revenue
Total Revenue4.3K4.3K4.3K18.6K5.2K
Cost of Revenue133.1K133.1K129.8K101.2K29.7K
Gross Profit(128.8K)(128.8K)(125.5K)(82.6K)(24.6K)
Operating Expenses
R&D Expense2.8B4.4M2.9M2.5M
SG&A Expense5.6B3.8M3.3M3.6M
General & Admin Expense
Selling & Marketing Expense
Other Expenses8.3M(8.4B)
Total Operating Expenses8.3M8.3M8.2M6.2M6.1M
Cost and Expenses8.4M8.4M8.4M6.3M6.1M
Operating Income (EBIT)(8.4M)(8.4M)(8.4M)(6.3M)(6.1M)
Non-Operating
Interest Income87.8K
Interest Expense753.0K753.0K500.5K354.1K243.2K
Net Interest Income(753.0K)(753.0K)(412.7K)(354.1K)(243.2K)
Other Non-Op Income/Expense(729.0K)(729.0K)(412.7K)(299.4K)(241.3K)
Non-Operating Income (excl Interest)(10.2K)(54.6K)(1.8K)
EBT (Pre-Tax Income)(9.1M)(9.1M)(8.8M)(6.6M)(6.4M)
Income Tax Expense
Bottom Line
Net Income(9.1M)(9.1M)(8.8M)(6.6M)(6.4M)
Earnings from Cont. Ops(9.1M)(9.1M)(8.8M)(6.6M)(6.4M)
Earnings from Discont. Ops
Bottom Line Net Income(9.1M)(9.1M)(8.8M)(6.6M)(6.4M)
Per Share
Basic EPS($3.92)($3.48)($9.34)($18.74)($79.92)
Diluted EPS($3.92)($3.48)($9.34)($18.74)($79.92)
Revenue Per Share$0.00$0.00$0.00$0.05$0.06
Shares
Basic Shares Outstanding3.2M2.6M93825735252079505
Diluted Shares Outstanding3.2M2.6M93825735252079505
Profitability Metrics
EBITDA(8.4M)(8.4M)(8.2M)(6.2M)(6.1M)
D&A128.0K95.1K26.9K
EBIT(8.4M)(8.4M)(8.4M)(6.3M)(6.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jan 1, 2026